The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Here, AGER is linked to combined pulmonary fibrosis-emphysema syndrome.